Thanks for printing!  Don't forget to come back to GlassRatner Advisory & Capital Group LLC for fresh articles!

GlassRatner's Team

Nick Welch

Senior Manager

[email protected]

Main: (404) 835-8858

Mobile: (404) 513-9298

Fax: (404) 435-8868

Areas of Expertise

  • Due Diligence
  • Interim Management
  • Valuation
  • Cash Flow Projections
  • Forensic Accounting
  • Regulatory Consulting
  • M&A
  • Accounting
  • Turnarounds/Restructurings

Industries

  • Construction
  • Healthcare
  • Hotel & Resorts
  • Retail
  • Restaurant

Experience

  • 16 Years of Relevant Experience

Education

  • BPP Professional Education - ACA qualification
  • SEEVIC College - Advance Level English, Law and Psychology
  • King John School (Higher Education) 6 GCSE grades A-C

Professional Designations

  • ACA
  • FMAAT

Nick Welch, FCA FMAAT, joined GlassRatner in 2017 from the firm’s UK affiliate Begbies Traynor Group plc (“BTG”).  BTG and GlassRatner are both founding members of BTG Global Advisory.  Nick was awarded the TMA’s (UK) “Young Turnaround Professional of the Year Award 2015” for his contributions to the profession.

Nick is a Senior Manager in the Advisory and Restructuring practice at GlassRatner and specializes in Business Valuation, Mergers & Acquisitions and Litigation Support. His notable recent assignments in the US and UK include:

Refinancing, Mergers & Acquisitions

  • Refinancing of a $33m Revenue Cancer Diagnostic Medical Laboratory in Atlanta;
  • Refinancing of $16m bank club debt package of a non-profit organization; 
  • Fundraising for a smartphone application in the music messaging space; and
  • Sell-Side Advisory and Marketing of a founder-owned $3.5m revenue training school for retirement purposes;

Valuation

  • Valuation of a Revenue of $36m SaaS company for the Healthcare sector for GAAP impairment testing and s409A;
  • Valuation of a franchisor of fast food operations (revenue $7m) and an associated wholesale fresh foods producer (revenue $70m) for the purposes of a negotiation to execute a buy-out/share swap between the minority and majority shareholder;
  • Valuation of a FinTech company with a $600m ‘near-prime’ consumer loan portfolio;
  • Purchase Price Allocation Valuation for the acquisition of several healthcare organizations combined revenues of $10m;
  • Valuation of a publicly listed private equity fund’s portfolio of investments for a solvent liquidation. The portfolio contained 7 private trading companies valued between $80m and $90m (£60m to £70m);
  • Valuation of a $4m (£3m) revenue recruitment business for a sale of the business; and
  • Valuation of the share capital of a software provider with revenues of $3m (£2m) involving a minority shareholder dispute for an out of court settlement mediation.

Financial Due Diligence

  • Buy-Side Financial Due Diligence for a private equity client acquiring a stock-broking/market making company for $4m (£3m). Guided through change of control process and capital adequacy regulatory criteria pre and post-acquisition;
  • Buy-Side Financial Due Diligence for a private equity client acquiring a global payment procession and gateway provider being. Transaction value $36m (€30m).  Sell-side advisors being Houlihan Lokey who operated a strict process and deadlines;
  • Buy-Side Financial Due Diligence of a $500m revenue micro-loan FinTech group based in Africa; and
  • Production of a litigation support paper for a damages claim brought by a Class Action against a nightclub. Identified potential damages of $18.5m.

Litigation Support

  • Production of a litigation support paper for a Contentious Insolvency case involving the Director of a luxury property developer in London’s West-End who had liquidated the company after extracting preference funds. The litigation was successful and enabled a $1.6m (£1.2m) recovery to unsecured creditors; and
  • Forensic investigation and transaction tracing of funds of a divested subsidiary of an acclaimed touring band where management fees had been diverted contrary to the terms of the contract.

Interim Turnaround Management

  • 7-month Interim Turnaround Assignment in a $200m (£160m) National Health Service (NHS) hospital in the UK placed into ‘Special Measures’ by its regulator. Nick led four key projects, worth £16m in profit efficiencies that focused around improving income, consultant performance, minimising agency staff spend and service contract viability reviews;

When Nick joined BTG in 2012, he initially specialized in Independent Business/Solvency Reviews advising clearing banks (Barclays, Lloyds, Santander and HSBC) on solutions for their ‘Special Assets’ portfolios across many sectors including Travel, Private and Public Healthcare, Property, Retail and Financial Services. The reports typically involved assessment of financial performance, capital structures, debt serviceability, cash flow management and strategy reviews.

Begin Your Journey to Clarity

Contact GlassRatner